GIP
BIOL

Granite Investment Partners’s Biolase, Inc. BIOL Stock Holding History

Granite Investment Partners’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-76
Closed -$924K – 315
2017
Q2 		$924K Sell
76
-4
-5% -$59.4K 0.06% 241
2017
Q1 		$1.35M Buy
80
+6
+8% +$109K 0.09% 197
2016
Q4 		$1.29M Buy
74
+31
+72% +$613K 0.09% 205
2016
Q3 		$946K Buy
+43
New +$765K 0.07% 246

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Granite Investment Partners's BIOL Position: Q3 2017 in Review

Granite Investment Partners sold out of Biolase, Inc. (BIOL) in Q3 2017, closing a stake of 76 shares — an estimated $924K sold.

Granite Investment Partners first reported a position in BIOL in Q3 2016 and held it in 4 quarters. The position peaked at $1.35M in Q1 2017. 28 funds tracked by Wall St. Rank hold BIOL as of Q3 2017.

  • Granite Investment Partners reported no remaining Biolase, Inc. position as of Q3 2017 after selling out during the quarter.
  • Granite Investment Partners sold 76 Biolase, Inc. shares in Q3 2017, an estimated $924K.
  • Granite Investment Partners first reported a position in Biolase, Inc. in Q3 2016 and held it in 4 quarters.
  • Granite Investment Partners's Biolase, Inc. position peaked at $1.35M in Q1 2017.
  • 28 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2017.

Based on Granite Investment Partners's 13F filing for Q3 2017, filed 8 Nov 2017.